Transaction #24608 · Form 4 · 0001005817-26-000137
TOMPKINS FINANCIAL CORP · Other acquisition · Common Stock
TOMPKINS FINANCIAL CORP · Transacted September 14, 2026 · Filed October 19, 2026
What does this filing report?
An SEC Form 4 filing for TOMPKINS FINANCIAL CORP records an other acquisition involving Common Stock on September 14, 2026. The reported quantity was 1.002. The filing date is October 19, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- TOMPKINS FINANCIAL CORP
- Company CIK
- 0001005817
- Security type
- Non-derivative
- Acquisition type
- Other acquisition · Code L
- Quantity acquired
- 1.002
- Reported price
- 99.84
- Reference value
- 100.03968
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 7,342.064
- Ownership description
- Not reported
- SEC acceptance time
- Oct 19, 2026, 3:56 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- DeMilia David M ↗
EVP, Pres of TCB Hudson Valley
CIK 0001866122
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Optional cash purchase through Tompkins Financial Dividend Reinvestment and Stock Puchase and Sale Plan.
- F2
- Shares withheld for Option cost and taxes
- F3
- Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a five-year vesting schedule, with 0% vesting in year one and 25% vesting in years two through five. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.